Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NBTY Eschews Ephedra, Eyes Acquisitions In Back Half Of Fiscal ’05

This article was originally published in The Tan Sheet

Executive Summary

NBTY's decision to stay out of the ephedra market could prove to be a bellwether for major dietary supplement manufacturers
Advertisement

Related Content

NBTY “Tough Quarter” Caused By Vitamin E Sales, Stalled Market - Rudolph
NBTY “Tough Quarter” Caused By Vitamin E Sales, Stalled Market - Rudolph
NBTY “Tough Quarter” Caused By Vitamin E Sales, Stalled Market - Rudolph
NBTY Broadens Health Food Store Presence With Solgar, SISU Acquisitions
NBTY Broadens Health Food Store Presence With Solgar, SISU Acquisitions
NBTY Broadens Health Food Store Presence With Solgar, SISU Acquisitions
Utah Court Overturns Ephedra Ban For Low-Dose Products
Utah Court Overturns Ephedra Ban For Low-Dose Products

Topics

Advertisement
UsernamePublicRestriction

Register

PS098143

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel